Ads
related to: amgen us careers- Part time jobs
All available Jobs listed
Find your New Job
- Sign up for free
Right role for the right Candidate
Explore millions of Vacancies
- Apprenticeships
Find the right Opportunity
for You
- Airport Jobs
Find your next Job
Explore all available Vacancies
- Part time jobs
Employment.org has been visited by 100K+ users in the past month
Large Employment Site (>10 Million Unique Visitors Per Month) - TAtech
Search results
Results from the WOW.Com Content Network
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total.
In October 2011, he was appointed to the Amgen board of directors. Bradway was named CEO of Amgen in May 2012, and chairman of the board in January 2013. [5] During Bradway’s tenure as CEO, Amgen's annual revenue increased from $17.3 billion in 2012 [8] to $26 billion in 2021, [9] and annual R&D investment increased to $4.2 billion in 2020. [10]
Raymond Joseph Deshaies (born September 25, 1961) is an American biochemist and cell biologist. He is senior vice president of global research at Amgen and a visiting associate at the California Institute of Technology (Caltech).
The jobs will pay an average wage of $119,510. Amgen received local incentives worth more than $35 million for the expansion, which is scheduled to open by 2025.
The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung ...
Amgen added Uplizna via a $27.8 billion acquisition of Horizon Therapeutics and recorded sales of $80 million in the first quarter of 2024. ... This article Amgen Seeks Expanded US Approval For ...
Alan J. Russell (born August 8, 1962 in Salford, Greater Manchester UK), is Vice President of Biologics for Amgen, one of the world’s leading Biopharmaceutical companies. Until 2020, Alan was the Highmark Distinguished Career Professor and Director of the Disruptive Health Technology Institute at Carnegie Mellon University. From 2013 through ...
Kevin W. Sharer (born March 2, 1948), is an American businessman who was chairman/CEO of the biotechnology company Amgen from 2000 to 2012. He later joined the faculty of Harvard Business School teaching RC Strategy and General Management. [1] [2] [3]